Prostate stereotactic ablative body radiotherapy: Long-terms outcome

被引:0
|
作者
Beltramo, G. [1 ]
Bergantin, A. [1 ]
Martinotti, A. S. [1 ]
Vite, C. [1 ]
Ria, F. [1 ]
Invernizzi, M. [1 ]
Bianchi, L. C. [1 ]
机构
[1] Ctr Diagnostico Italiano, Cyberknife Ctr, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1318
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [1] Stereotactic ablative body radiotherapy in patients with prostate cancer
    Loblaw, Andrew
    Liu, Stanley
    Cheung, Patrick
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 330 - 340
  • [2] Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer
    Niazi, Tamim
    Elakshar, Sara
    Stroian, Gabriela
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 351 - 358
  • [3] Implementation of Stereotactic Ablative Radiotherapy (Stereotactic Body Radiotherapy)
    Kirkbride, P.
    Hoskin, P. J.
    CLINICAL ONCOLOGY, 2012, 24 (09) : 627 - 628
  • [4] Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
    Ma, Ting Martin
    Lilleby, Oscar
    Lilleby, Wolfgang A.
    Kishan, Amar U.
    CANCERS, 2020, 12 (12) : 1 - 20
  • [5] The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer
    Dreosti, Marcus
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 71 - 71
  • [6] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [7] OUTCOME OF STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) IN PATIENTS WITH OLIGO-METASTATIC PROSTATE CANCER IN SOUTH AUSTRALIAN POPULATION
    Salim, Ayesha
    Hocking, Christopher
    Le, Hien
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 57 - 58
  • [8] Clinical outcome of stereotactic body radiotherapy for localized prostate cancer: long-term results
    Kim, H. J.
    Lee, J. S.
    Kim, W. C.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2020, 18 (03): : 383 - 388
  • [9] Feasibility and safety of MR-guided stereotactic ablative body radiotherapy for Prostate Cancer
    Geddes, L.
    Crawford, D.
    Batumalai, V.
    Pagulayan, C.
    Hogan, L.
    Jelen, U.
    Loo, C.
    Dunkerley, N.
    Picton, M.
    Alvares, S.
    Sampaio, S.
    Heinke, M.
    Twentyman, T.
    Jameson, M.
    De Leon, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S288 - S289
  • [10] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer
    Loblaw, Andrew
    CANCER JOURNAL, 2020, 26 (01): : 38 - 42